HUM vs INM · P/E 39, rev $129.66B vs rev $4.9M
Humana Inc (HUM) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. INM currently screens at market cap $5.2M.
Not investment advice. Open the HUM and INM stock pages for the full models.
Not investment advice.